Mark Smith – Chief Financial Officer

Mr. Mark Smith is the Chief Financial Officer of Gevo. Mr. Smith was formerly the Chief Financial Officer of Replidyne, Inc., where he played a leadership role in completing the Company’s initial public offering and executing its strategic sale to Cardiovascular Systems, Inc. Prior to joining Replidyne, Mr. Smith served as senior Vice President of Finance, Treasurer, Chief Financial Officer and Chief Accounting Officer of Nabi Biopharmaceuticals.

Prior to joining Nabi, Mr. Smith served as Vice President of Finance and Administration and Chief Financial Officer of Neuromedical Systems Inc. He also served in various financial executive capacities at Genzyme Corporation and was the Chief Financial Officer of Genetrix Inc., prior to its sale to Genzyme in 1996. He commenced his professional career with the accounting firm Price Waterhouse (now PricewaterhouseCoopers) in both Australia and the United States.

Mr. Smith received a B.A. in accounting from the Canberra College of Advanced Education.